264 related articles for article (PubMed ID: 1314075)
1. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075
[TBL] [Abstract][Full Text] [Related]
2. Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells.
Ashraf J; Kunapuli S; Chilton D; Thompson EB
J Steroid Biochem Mol Biol; 1991 May; 38(5):561-8. PubMed ID: 2039752
[TBL] [Abstract][Full Text] [Related]
3. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Medh RD; Saeed MF; Johnson BH; Thompson EB
Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
[TBL] [Abstract][Full Text] [Related]
4. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis.
Thulasi R; Harbour DV; Thompson EB
J Biol Chem; 1993 Aug; 268(24):18306-12. PubMed ID: 8394364
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.
Miller AL; Webb MS; Thompson EB
Steroids; 2007 Sep; 72(9-10):673-81. PubMed ID: 17606285
[TBL] [Abstract][Full Text] [Related]
6. Interactions of the phenylpyrazolo steroid cortivazol with glucocorticoid receptors in steroid-sensitive and -resistant human leukemic cells.
Thompson EB; Srivastava D; Johnson BH
Cancer Res; 1989 Apr; 49(8 Suppl):2253s-2258s. PubMed ID: 2702665
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.
Yuh YS; Thompson EB
J Biol Chem; 1989 Jun; 264(18):10904-10. PubMed ID: 2659598
[TBL] [Abstract][Full Text] [Related]
8. Coordinate regulation of glucocorticoid receptor and c-jun gene expression is cell type-specific and exhibits differential hormonal sensitivity for down- and up-regulation.
Barrett TJ; Vig E; Vedeckis WV
Biochemistry; 1996 Jul; 35(30):9746-53. PubMed ID: 8703946
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells.
Zhou F; Medh RD; Thompson EB
J Steroid Biochem Mol Biol; 2000; 73(5):195-202. PubMed ID: 11070348
[TBL] [Abstract][Full Text] [Related]
10. Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts.
Zhou F; Thompson EB
Mol Endocrinol; 1996 Mar; 10(3):306-16. PubMed ID: 8833659
[TBL] [Abstract][Full Text] [Related]
11. Two glucocorticoid binding sites on the human glucocorticoid receptor.
Srivastava D; Thompson EB
Endocrinology; 1990 Oct; 127(4):1770-8. PubMed ID: 2205477
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R
Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells.
Thompson EB; Thulasi R; Saeed MF; Johnson BH
Ann N Y Acad Sci; 1995 Jun; 761():261-75. PubMed ID: 7625725
[TBL] [Abstract][Full Text] [Related]
14. Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells.
Thompson EB; Johnson BH
Recent Prog Horm Res; 2003; 58():175-97. PubMed ID: 12795419
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
16. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid receptors in human leukemias and related diseases.
Thompson EB; Smith JR; Bourgeois S; Harmon JM
Klin Wochenschr; 1985 Aug; 63(15):689-98. PubMed ID: 2413243
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
Medh RD; Wang A; Zhou F; Thompson EB
Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786
[TBL] [Abstract][Full Text] [Related]
19. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant.
Ramos RA; Meilandt WJ; Wang EC; Firestone GL
FASEB J; 1999 Jan; 13(1):169-80. PubMed ID: 9872941
[TBL] [Abstract][Full Text] [Related]
20. The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.
Yoshikawa N; Yamamoto K; Shimizu N; Yamada S; Morimoto C; Tanaka H
Mol Endocrinol; 2005 May; 19(5):1110-24. PubMed ID: 15677712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]